Blood Reviews,
Journal Year:
2023,
Volume and Issue:
60, P. 101075 - 101075
Published: March 20, 2023
ME/CFS
is
a
debilitating
chronic
condition
that
often
develops
after
viral
or
bacterial
infection.
Insight
from
the
study
of
Long
COVID/Post
Acute
Sequelae
COVID-19
(PASC),
post-viral
syndrome
associated
with
SARS-CoV-2
infection,
might
prove
to
be
useful
for
understanding
pathophysiological
mechanisms
ME/CFS.
Disease
presentation
similar
between
two
conditions,
and
subset
COVID
patients
meet
diagnostic
criteria
Since
characterized
by
significant
vascular
pathology
–
including
endothelial
dysfunction,
coagulopathy,
dysregulation
question
whether
not
same
biological
abnormalities
are
significance
in
arises.
Cardiac
have
while
now
been
documented
cohorts,
recent
studies
demonstrating
major
deficits
cerebral
blood
flow,
hence
dysregulation.
A
growing
body
research
accompanied
platelet
hyperactivation,
anomalous
clotting,
procoagulant
phenotype,
dysfunction.
Endothelial
damage
dysregulated
clotting
can
impair
substance
exchange
tissues,
result
hypoperfusion,
which
may
contribute
manifestation
certain
symptoms.
Here
we
review
literature
summarize
cardiovascular
haematological
findings
condition,
and,
this
context,
briefly
discuss
potential
role
previously-implicated
pathogens.
Overall,
cardiac
present
within
cohorts.
While
atherosclerotic
heart
disease
significantly
ME/CFS,
suboptimal
function
defined
reduced
output,
impaired
are,
these
do
appear
influenced
deconditioning.
Rather,
dysfunction
(autonomic)
nervous
system.
Plenty
recently
published
hyperactivity
as
well
processes.
It
particular
importance
determine
what
extent
symptom
severity,
if
systems
targeted
therapeutic
purposes.
Viral
reservoirs
herpesviruses
exist
most
likely
directly
indirectly.
This
highlights
studying
functioning,
vasculature,
coagulation
system
Public health reviews,
Journal Year:
2022,
Volume and Issue:
43
Published: March 15, 2022
Objectives:
To
synthesize
existing
evidence
on
prevalence
as
well
clinical
and
socio-economic
aspects
of
Long
COVID.
Methods:
An
umbrella
review
reviews
a
targeted
synthesis
their
primary
studies,
including
searches
in
four
electronic
databases,
reference
lists
included
reviews,
related
article
relevant
publications.
Results:
Synthesis
23
102
studies.
Prevalence
estimates
ranged
from
7.5%
to
41%
non-hospitalized
adults,
2.3%–53%
mixed
adult
samples,
37.6%
hospitalized
2%–3.5%
primarily
children.
Preliminary
suggests
that
female
sex,
age,
comorbidities,
the
severity
acute
disease,
obesity
are
associated
with
Almost
50%
studies
reported
some
degree
COVID-related
social
family-life
impairment,
long
absence
periods
off
work,
adjusted
workloads,
loss
employment.
Conclusion:
COVID
will
likely
have
substantial
public
health
impact.
Current
is
still
heterogeneous
incomplete.
fully
understand
COVID,
well-designed
prospective
representative
samples
be
essential.
JAMA Neurology,
Journal Year:
2022,
Volume and Issue:
79(5), P. 509 - 509
Published: March 8, 2022
Importance
Determining
the
long-term
impact
of
COVID-19
on
cognition
is
important
to
inform
immediate
steps
in
research
and
health
policy.
Objective
To
investigate
1-year
trajectory
cognitive
changes
older
survivors.
Design,
Setting,
Participants
This
cohort
study
recruited
3233
survivors
60
years
who
were
discharged
from
3
COVID-19–designated
hospitals
Wuhan,
China,
February
10
April
10,
2020.
Their
uninfected
spouses
(N
=
466)
as
a
control
population.
Participants
with
preinfection
impairment,
concomitant
neurological
disorder,
or
family
history
dementia
excluded,
well
those
severe
cardiac,
hepatic,
kidney
disease
any
kind
tumor.
Follow-up
monitoring
functioning
decline
took
place
at
6
12
months.
A
total
1438
438
individuals
included
final
follow-up.
was
categorized
nonsevere
following
American
Thoracic
Society
guidelines.
Main
Outcomes
Measures
The
main
outcome
change
1
year
after
patient
discharge.
Cognitive
during
first
second
6-month
follow-up
periods
assessed
using
Informant
Questionnaire
Decline
Elderly
Telephone
Interview
Status-40,
respectively.
Based
observed
2
periods,
trajectories
classified
into
4
categories:
stable
cognition,
early-onset
decline,
late-onset
progressive
decline.
Multinomial
conditional
logistical
regression
models
used
identify
factors
associated
risk
Results
Among
1317
screened,
participants
treated
for
(691
male
[48.05%]
747
female
[51.95%];
median
[IQR]
age,
69
[66-74]
years)
(222
[50.68%]
216
[49.32%];
67
completed
12-month
incidence
impairment
months
discharge
12.45%.
Individuals
cases
had
lower
Status-40
scores
than
(median
[IQR]:
severe,
22.50
[16.00-28.00];
nonsevere,
30.00
[26.00-33.00];
control,
31.00
[26.00-33.00]).
Severe
higher
(odds
ratio
[OR],
4.87;
95%
CI,
3.30-7.20),
(OR,
7.58;
3.58-16.03),
19.00;
9.14-39.51),
while
1.71;
1.30-2.27)
when
adjusting
sex,
education
level,
body
mass
index,
comorbidities.
Conclusions
Relevance
In
this
study,
survival
an
increase
longitudinal
highlighting
importance
measures
deal
challenge.
Journal of Clinical Medicine,
Journal Year:
2022,
Volume and Issue:
11(24), P. 7314 - 7314
Published: Dec. 9, 2022
Identification
of
predictors
long
COVID-19
is
essential
for
managing
healthcare
plans
patients.
This
systematic
literature
review
and
meta-analysis
aimed
to
identify
risk
factors
not
associated
with
Severe
Acute
Respiratory
Syndrome
Coronavirus
2
(SARS-CoV-2)
infection,
but
rather
potentially
predictive
the
development
COVID-19.
MEDLINE,
CINAHL,
PubMed,
EMBASE,
Web
Science
databases,
as
well
medRxiv
bioRxiv
preprint
servers
were
screened
through
15
September
2022.
Peer-reviewed
studies
or
preprints
evaluating
potential
pre-SARS-CoV-2
infection
long-lasting
symptoms
included.
The
methodological
quality
was
assessed
using
Quality
in
Prognosis
Studies
(QUIPSs)
tool.
Random-effects
meta-analyses
calculation
odds
ratio
(OR)
performed
those
where
a
homogenous
definition
used.
From
1978
identified,
37
peer-reviewed
one
Eighteen
articles
evaluated
age,
sixteen
sex,
twelve
medical
comorbidities
Overall,
single
reported
that
old
age
seems
be
(n
=
18);
however,
did
reveal
an
association
between
3;
OR
0.86,
95%
CI
0.73
1.03,
p
0.17).
Similarly,
revealed
female
sex
16);
which
confirmed
7;
1.48,
1.17
1.86,
0.01).
Finally,
such
pulmonary
disease
4),
diabetes
1),
obesity
6),
organ
transplantation
1)
also
identified
bias
most
(71%,
n
27/38)
moderate
high.
In
conclusion,
pooled
evidence
support
advancing
supported
factor
Long
some
previous
comorbidities.
Journal of Clinical Medicine,
Journal Year:
2022,
Volume and Issue:
11(6), P. 1541 - 1541
Published: March 11, 2022
Evidence
shows
that
a
substantial
proportion
of
patients
with
COVID-19
experiences
long-term
consequences
the
disease,
but
predisposing
factors
are
poorly
understood.
We
conducted
systematic
review
and
meta-analysis
to
identify
present
during
hospitalization
associated
an
increased
risk
exhibiting
new
or
persisting
symptoms
(Post-COVID-19
Syndrome,
PCS).
MedLine
WebOfScience
were
last
searched
on
30
September
2021.
included
English
language
clinical
trials
observational
studies
investigating
prognostic
for
PCS
in
adults
previously
hospitalized
COVID-19,
reporting
at
least
one
individual
prospective
follow-up
minimum
12
weeks.
Two
authors
independently
assessed
bias,
which
was
judged
generally
moderate.
Risk
analysis
if
their
association
investigated
by
two
studies.
To
summarize
effect
each
factor
(or
group
factors),
odds
ratios
estimated
using
raw
data.
Overall,
20
articles
met
inclusion
criteria,
involving
13,340
patients.
Associations
statistically
significant
factors:
female
sex
any
(OR
1.52;
95%
CI
1.27–1.82),
mental
health
1.67,
1.21–2.29)
fatigue
1.54,
1.32–1.79);
acute
disease
severity
respiratory
1.66,
1.03–2.68).
The
I²
statistics
tests
calculated
quantify
degree
study
heterogeneity.
This
is
first
measuring
between
sequelae.
role
as
independent
must
be
confirmed
robust
longitudinal
longer
follow-up.
Identifying
populations
greatest
can
enable
development
targeted
prevention
management
strategies.
Systematic
registration:
PROSPERO
CRD42021253467.
Current Medical Research and Opinion,
Journal Year:
2022,
Volume and Issue:
38(6), P. 901 - 909
Published: Feb. 15, 2022
Post-COVID
syndrome
(PCS)
is
a
poorly
known
entity.
An
underlying
chronic,
low-grade
inflammation
(LGI)
has
been
theorized
as
pathophysiological
mechanism.
Available
data
on
biomarkers
in
PCS
show
conflicting
results.
Our
aim
was
to
know
whether
subjects
with
present
higher
levels
of
inflammatory
markers,
after
mild
COVID-19.Analytical
cross-sectional
study.
Cases
COVID-19
community
setting
were
included.
We
collected
epidemiological
(age,
sex,
BMI,
smoking,
comorbidities),
variables
the
acute
(duration,
symptoms),
and
at
3
months
phase
(symptoms
laboratory
test).
Serum
C-reactive
protein
(CRP),
neutrophil
lymphocyte
counts,
neutrophil/lymphocyte
ratio
(NLR),
lactate
dehydrogenase,
ferritin,
fibrinogen,
D-dimer
analysed.
LGI
defined
CRP
>0.3
<1.0
mg/dL.
A
subject
classified
+
if
presented
signs
symptoms
>12
weeks
an
infection
consistent
COVID-19.
Five
composite
indices
(C1-C5)
developed,
combining
upper
ranges
distributions.
Multivariate
analyses
performed.We
analysed
121
cases
(mean
age
=
45.7
years,
56.2%
women).
Among
symptoms,
women
frequency
fatigue
(54.4%
vs
30.2%;
p
.008).
affected
35.8%
20.8%
men
(p
.07),
most
reported
(42.8%),
anosmia
(40%),
ageusia
(22.8%),
dyspnea
(17.1%)
myalgia
(11.4%).
Neutrophil
count,
NLR,
fibrinogen
showed
best
correlations
selected
develop
indices.
In
PCS+,
C1,
C3
C4
more
frequently
met,
while
C2,
C5
range
LGI.
Anosmia,
related
sex
differences.
Fibrinogen
persistent
(510
±
82
mg/dL
394
87;
.013).
multivariable
analysis,
woman
count
above
median,
or
level
NLR
highest
tertile,
had
4-5-fold
increased
risk
prevalent
PCS.
man
LGI,
10-17-fold
PCS.The
obtained
study
seems
demonstrate
association
between
range.
Furthermore,
appear
useful
detecting
relationships
slight
elevations
PCS,
our
identifies
relevant
differences
markers
regarding
Work,
Journal Year:
2023,
Volume and Issue:
74(4), P. 1179 - 1186
Published: March 10, 2023
BACKGROUND:
Long
COVID
describes
a
condition
with
symptoms
that
linger
for
months
to
years
following
acute
COVID-19.
Many
of
these
are
like
those
experienced
by
patients
myalgic
encephalomyelitis/chronic
fatigue
syndrome
(ME/CFS).
OBJECTIVE:
We
wanted
determine
if
people
post-exertional
malaise
(PEM),
the
hallmark
symptom
ME/CFS,
and
so,
how
it
compared
PEM
ME/CFS.
METHODS:
A
questionnaire
asked
about
domains
including
triggers,
experience,
recovery,
prevention
was
administered
80
seeking
care
at
Bateman
Horne
Center.
Their
responses
were
given
151
ME/CFS
using
chi-square
tests
independence.
RESULTS:
All
but
one
respondent
reported
having
PEM.
There
many
significant
differences
in
types
during
PEM,
ways
recover
prevent
between
Similarities
included
low
medium
physical
cognitive
exertion
trigger
fatigue,
pain,
immune
reaction,
neurologic,
orthostatic
intolerance,
gastrointestinal
rest
from
pacing
CONCLUSION:
People
experience
This
may
be
due
newness
COVID,
not
knowing
what
exertional
intolerance
is
or
manage
it.
PLoS Medicine,
Journal Year:
2023,
Volume and Issue:
20(4), P. e1004194 - e1004194
Published: April 17, 2023
Incidence
of
long
COVID
in
the
elderly
is
difficult
to
estimate
and
can
be
underreported.
While
sometimes
considered
a
novel
disease,
many
viral
or
bacterial
infections
have
been
known
cause
prolonged
illnesses.
We
postulate
that
some
influenza
patients
might
develop
residual
symptoms
would
satisfy
diagnostic
criteria
for
COVID,
condition
we
call
"long
Flu."
In
this
study,
incidence
Flu
among
Medicare
using
World
Health
Organization
(WHO)
consensus
definition.
compare
incidence,
symptomatology,
healthcare
utilization
between
patients.
BMJ Open,
Journal Year:
2024,
Volume and Issue:
14(1), P. e077886 - e077886
Published: Jan. 1, 2024
Post-COVID-19
conditions
(PCC)
is
an
umbrella
term
that
encompasses
a
range
of
signs,
symptoms
and
present
weeks
after
the
acute
phase
SARS-CoV-2
infection.
This
systematic
literature
review
summarises
heterogeneous
methodology
used
to
measure
PCC
across
real-world
studies
highlights
trends
by
region,
age
group,
follow-up
period
data
source.
Methods
Medline,
EMBASE
Cochrane
Library
were
searched
supplemented
with
conference
grey
searches.
Eligible
included
individuals
(1)
or
(2)
positive
test
COVID-19
diagnosis
who
followed
over
time.
Included
published
in
English
between
1
January
2020
14
November
2022.
Findings
Of
291
publications
included,
175
(60%)
confirmed
time
for
116
(40%)
prespecified
definition.
There
was
substantial
heterogeneity
study
design,
geography,
conditions/symptoms
assessed
their
classification
duration
follow-up.
Among
using
definition,
author-defined
criteria
(51%)
more
common
than
recommended
major
public
health
organisations
(19%).
Measurement
periods
outcomes
from
date
primarily
3
<6
months
(39.2%),
6
<12
(27.5%)
<3
(22.9%).
When
classified
organ/system,
constitutional-related
most
frequently
adult
(86%)
paediatric
(87%)
populations.
Within
constitutional
symptoms,
fatigue
(91.6%)
(95.0%)
populations,
fever/chills
(37.9%
55%,
respectively).
Conclusions
definitions
are
heterogenous
studies,
which
limits
reliable
comparisons
studies.
However,
some
similarities
observed
terms
measured
PCC-associated
symptoms/conditions,
may
aid
clinical
management
patients
PCC.
CRD42022376111.